-
Philippine aquatic product unloading volume continues to increase
Time of Update: 2021-04-17
html" class="zdbq" title="Food information related to aquatic products" target="_blank"> According to a report by the Philippine "Star" on April 7, the supply of foodmate.
html" class="zdbq" title="" target="_blank">aquatic products in the National Capital Region and several areas in central and southern Luzon continued to increase in March due to the end of the fishing foodmate.
-
KRAS inhibitor Qinhao Pharmaceutical submits its first IND in China
Time of Update: 2021-04-14
According to the press release, GH35 is a KRAS G12C inhibitor under development, which is also the first clinical trial application submitted by Qin Hao Pharmaceutical in China.
Screenshot source: CDE official websiteGH35 is a KRAS G12C inhibitor developed by Qinhao Pharmaceutical.
-
28 departments jointly issued a document: Supporting doctors' Internet practice
Time of Update: 2021-04-14
The document also clarified that the data interface between Internet hospitals and physical medical institutions should be opened up, and the interconnection of medical insurance data will be gradually promoted , and the provincial Internet medical service supervision platform will be improved.
-
New indication for AstraZeneca osimertinib is about to be approved
Time of Update: 2021-04-14
In December 2020, based on ADAURA research data, osimertinib was approved in the United States for the use of epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 L858R mutation in non-small cell lung cancer (NSCLC) adult patient tumors Adjuvant treatment after resection.
-
Can rheumatism patients get the new crown vaccine? Do I need to adjust the medication before and after vaccination
Time of Update: 2021-04-13
2. Due to the heterogeneity caused by disease and treatment-related factors, combined with the influence of age and gender, compared with the general population, patients with rheumatism have a higher risk of hospitalization for new coronary pneumonia and a worse outcome.
-
6 billion oseltamivir or competitor of welcome drug
Time of Update: 2021-03-25
Zhongsheng Pharmaceutical's 2020 semi-annual report shows that ZSP1273 tablets are the first domestic small molecule RNA polymerase inhibitor to treat influenza A that has completed a phase II clinical trial-a new anti-influenza drug with a brand-new target.
-
Announcement of the Huaibei Municipal Market Supervision Administration on Issuing the 31st Phase of Food Safety Supervision and Sampling Inspection Information in 2020
Time of Update: 2021-03-20
html" class="zdbq" title="Consumer-related food information" target="_blank">consumer 's right to know about consumption, the random inspection information is now announced as follows: The sampling of the foodmate.
html" class="zdbq" title="Consumer-related food information" target="_blank">consumers The sampling of the foodmate.
html" class="zdbq" title="Catering-related food information" target="_blank">Food foodmate.
-
Run away from the PD-L1 and the $10 billion double-resistant market Corning Jerry's IPO in Hong Kong today
Time of Update: 2021-03-04
01 Double Resistance Race: Another Upcoming According to the previously disclosed prospecto, Corning Jerry's current product pipeline includes eight tumor candidate drugs, four of which are in the clinical stage, with progress from Clinical Phase I to Critical Phase II/III.
-
Chinese medicine is quickly integrated into the international medical system
Time of Update: 2021-02-22
In order to better serve the health of all peoples, China has continuously summarized and contributed to the practical experience of developing Chinese medicine, and has made unremitting efforts to promote traditional medicine, represented by Chinese medicine, to the world.
-
Official notice: 177 drugs have been discontinued
Time of Update: 2021-02-22
on the evening of November 16th, Gansu Provincial Public Resources Trading Bureau issued a notice on matters related to the cancellation of the winning bid registration network for applications for
-
European regulators are positive about Sogroya's treatment of adult growth hormone deficiency
Time of Update: 2021-02-03
Novo Nordisk announced today that the European Medicines Agency's (EMA) Human Medicines Board (CHMP) has taken a positive approach to the weekly Sogroya® and recommended approval for the market for the treatment of adult patients with growth hormone deficiency (AGHD).
-
Hesco's new Class 1 drug, Cyclophenol, has been approved for sale
Time of Update: 2020-12-27
On December 14, NMPA's official website revealed that the New Class 1 drug HSK3486 Emulsion (Cyclophenol) from Liaoning Haisco was approved for the diagnosis and treatment of sedation and/or anesthesia in the digestive tract endoscopy.
-
Medical marijuana may not necessarily reduce chronic non-cancerous pain, the study said
Time of Update: 2020-12-18
researchers from institutions such as the Australian National Centre for Drug and Alcohol Research recruited 1,514 patients with chronic non-cancerous pain at community pharmacies to assess their pain conditions, health status and drug and medical cannabis use each year.
-
Nature's assessment suggests that reducing the spread of the new crown 6 tricks is the most effective
Time of Update: 2020-12-16
At the same time, studies and validation results show that the most effective non-drug interventions are the elimination of small gatherings, the closure of educational facilities, the implementation of border controls, the control of individual actions, the national blockade and the increase in the supply of personal protective equipment.
-
Notice of the Guangxi Zhuang Autonomous Region Market Supervision And Administration on the Analysis of Food Safety Supervision and Sampling in the Second Quarter of 2020 (No. 86 of 2020
Time of Update: 2020-12-07
According to the food safety supervision and sampling work deployment and planning arrangements of the Guangxi Zhuang Autonomous Region Market Supervision Administration, in the second quarter, a tot
